On September 28, 2022, the company announced that it has extended its plan duration till October 2, 2042.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,300 KRW | 0.00% | -0.10% | -12.49% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-12.49% | 115M | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+13.30% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.